Some of the best links we picked up around the internet
Caribou Biosciences reported last week that its off-the-shelf, CRISPR-edited anti-CD19 CAR-T, vispa-cel (formerly CB-010), achieved response rates and...
At yesterday's CRISPRMED25 Virtual Event, five oral presenters and eleven poster contributors from academia and industry shared advances across a...